CRSCARPENTER TECHNOLOGY CORPORATIONLarge cap · $28.16B · FY ending 2025-06-30
$566.85-2.03% · 2026-07-13 · EOD
50/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality73
narrow moat · ROIC 17%Value28
P/E 76.4 · 86% of 12-mo rangeMomentum83
golden · price above 200-daySmart Money16
selling · 2 funds · 0P/6S insidersBullish stackGolden crossAbove 200-day
vs S&P 500+67.8%
6-mo excess Trailing performance1M +8.4%
3M +30.2%
6M +76.4%
YTD +67.5%
1Y +104.8%
P/E vs its last 12 months (our price history): 31.3 low → 83.5 high
Current price sits at the 86th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Narrow moat — ROIC 17%
Piotroski F8/9
fundamental strength Altman ZSafe
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 20%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio10.7%
comfortable Shareholder yield0.5%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net selling0P / 6S insiders · 2 funds hold · 0 Congress buys
Recent insidersKAROL STEVEN E · DirectorSELL$975,479
HART ANASTASIOS JOHN · DirectorSELL$115,470
AKINS MARSHALL D · VP and Chief Comm OfficerSELL$5.2M
HART ANASTASIOS JOHN · DirectorSELL$317,897
Fund holders (13F)Lone Pine Capital (Steve Mandel)$716.5M5.7% of book
Third Point (Dan Loeb)
Ahealth · 89/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.